APO Research
Talk to an analyst

APO RESEARCH · REPORT

Budesonide

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

Selected research

Industry Growth & Trends

Global Budesonide Industry Growth and Trends Forecast to 2032

22 December 2025102 pages

Choose your research edition.

Industry ResearchBudesonide Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Budesonide Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Budesonide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Budesonide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Budesonide Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.

The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Budesonide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Budesonide market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Budesonide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Budesonide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Budesonide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Budesonide Market by Company

AstraZeneca

Teva

Mylan

Sandoz

Cosmo Pharmaceuticals

Salix

Chiesi Farmaceutici

Orion Corporation

Cipla

Synmosa Biopharma

Lunan Better Pharma

Shanghai Sine Promod

Budesonide Segment by Type

Injectable Suspension

Aerosols

Inhalation Powder

Tablet and Capsule

Budesonide Segment by Application

Respiratory Disease Treatment

Nose Disease Treatment

Inflammatory Bowel Disease Treatment

Others

Budesonide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Budesonide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injectable Suspension Table 2. Major Company of Aerosols Table 3. Major Company of Inhalation Powder Table 4. Major Company of Tablet and Capsule Table 5. Global Budesonide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Budesonide Sales by Type (2021-2026) & (M Units) Table 7. Global Budesonide Sales Market Share in Volume by Type (2021-2026) Table 8. Global Budesonide Sales by Type (2021-2026) & (US$ Million) Table 9. Global Budesonide Sales Market Share in Value by Type (2021-2026) Table 10. Global Budesonide Price by Type (2021-2026) & (USD/K Units) Table 11. Global Budesonide Sales by Type (2027-2032) & (M Units) Table 12. Global Budesonide Sales Market Share in Volume by Type (2027-2032) Table 13. Global Budesonide Sales by Type (2027-2032) & (US$ Million) Table 14. Global Budesonide Sales Market Share in Value by Type (2027-2032) Table 15. Global Budesonide Price by Type (2027-2032) & (USD/K Units) Table 16. North America Budesonide Sales by Type (2021-2026) & (M Units) Table 17. North America Budesonide Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Budesonide Sales by Type (2021-2026) & (M Units) Table 19. Europe Budesonide Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Budesonide Sales by Type (2021-2026) & (M Units) Table 21. Asia-Pacific Budesonide Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Budesonide Sales by Type (2021-2026) & (M Units) Table 23. Latin America Budesonide Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Budesonide Sales by Type (2021-2026) & (M Units) Table 25. Middle East and Africa Budesonide Sales by Type (2021-2026) & (US$ Million) Table 26. Budesonide Industry Trends Table 27. Budesonide Industry Drivers Table 28. Budesonide Industry Opportunities and Challenges Table 29. Budesonide Industry Restraints Table 30. Global Budesonide Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Budesonide Revenue Market Share by Company (2021-2026) Table 32. Global Budesonide Sales by Company (2021-2026) & (M Units) Table 33. Global Budesonide Sales Share by Company (2021-2026) Table 34. Global Budesonide Market Price by Company (2021-2026) & (USD/K Units) Table 35. Global Budesonide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Budesonide Major Company Production Sites and Headquarters Table 37. Global Budesonide Company, Product Type & Application Table 38. Global Budesonide Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Budesonide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Budesonide Sales by Region (2021-2026) & (M Units) Table 43. Global Budesonide Sales Market Share in Volume by Region (2021-2026) Table 44. Global Budesonide Sales by Region (2021-2026) & (US$ Million) Table 45. Global Budesonide Sales Market Share in Value by Region (2021-2026) Table 46. Global Budesonide Sales (M Units), Value (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 47. Global Budesonide Sales by Region (2027-2032) & (M Units) Table 48. Global Budesonide Sales Market Share in Volume by Region (2027-2032) Table 49. Global Budesonide Sales by Region (2027-2032) & (US$ Million) Table 50. Global Budesonide Sales Market Share in Value by Region (2027-2032) Table 51. Global Budesonide Sales (M Units), Value (US$ Million), Price (USD/K Units) and Gross Margin (2027-2032) Table 52. Global Budesonide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Budesonide Sales by Application (2021-2026) & (M Units) Table 54. Global Budesonide Sales Market Share in Volume by Application (2021-2026) Table 55. Global Budesonide Sales by Application (2021-2026) & (US$ Million) Table 56. Global Budesonide Sales Market Share in Value by Application (2021-2026) Table 57. Global Budesonide Price by Application (2021-2026) & (USD/K Units) Table 58. Global Budesonide Sales by Application (2027-2032) & (M Units) Table 59. Global Budesonide Sales Market Share in Volume by Application (2027-2032) Table 60. Global Budesonide Sales by Application (2027-2032) & (US$ Million) Table 61. Global Budesonide Sales Market Share in Value by Application (2027-2032) Table 62. Global Budesonide Price by Application (2027-2032) & (USD/K Units) Table 63. North America Budesonide Sales by Application (2021-2026) & (M Units) Table 64. North America Budesonide Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Budesonide Sales by Application (2021-2026) & (M Units) Table 66. Europe Budesonide Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Budesonide Sales by Application (2021-2026) & (M Units) Table 68. Asia-Pacific Budesonide Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Budesonide Sales by Application (2021-2026) & (M Units) Table 70. Latin America Budesonide Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Budesonide Sales by Application (2021-2026) & (M Units) Table 72. Middle East and Africa Budesonide Sales by Application (2021-2026) & (US$ Million) Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 76. AstraZeneca Budesonide Product Portfolio Table 77. AstraZeneca Recent Development Table 78. Teva Company Information Table 79. Teva Business Overview Table 80. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 81. Teva Budesonide Product Portfolio Table 82. Teva Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 86. Mylan Budesonide Product Portfolio Table 87. Mylan Recent Development Table 88. Sandoz Company Information Table 89. Sandoz Business Overview Table 90. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 91. Sandoz Budesonide Product Portfolio Table 92. Sandoz Recent Development Table 93. Cosmo Pharmaceuticals Company Information Table 94. Cosmo Pharmaceuticals Business Overview Table 95. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 96. Cosmo Pharmaceuticals Budesonide Product Portfolio Table 97. Cosmo Pharmaceuticals Recent Development Table 98. Salix Company Information Table 99. Salix Business Overview Table 100. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 101. Salix Budesonide Product Portfolio Table 102. Salix Recent Development Table 103. Chiesi Farmaceutici Company Information Table 104. Chiesi Farmaceutici Business Overview Table 105. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 106. Chiesi Farmaceutici Budesonide Product Portfolio Table 107. Chiesi Farmaceutici Recent Development Table 108. Orion Corporation Company Information Table 109. Orion Corporation Business Overview Table 110. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 111. Orion Corporation Budesonide Product Portfolio Table 112. Orion Corporation Recent Development Table 113. Cipla Company Information Table 114. Cipla Business Overview Table 115. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 116. Cipla Budesonide Product Portfolio Table 117. Cipla Recent Development Table 118. Synmosa Biopharma Company Information Table 119. Synmosa Biopharma Business Overview Table 120. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 121. Synmosa Biopharma Budesonide Product Portfolio Table 122. Synmosa Biopharma Recent Development Table 123. Lunan Better Pharma Company Information Table 124. Lunan Better Pharma Business Overview Table 125. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 126. Lunan Better Pharma Budesonide Product Portfolio Table 127. Lunan Better Pharma Recent Development Table 128. Shanghai Sine Promod Company Information Table 129. Shanghai Sine Promod Business Overview Table 130. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2021-2026) Table 131. Shanghai Sine Promod Budesonide Product Portfolio Table 132. Shanghai Sine Promod Recent Development Table 133. North America Budesonide Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 134. North America Budesonide Sales by Country (2021-2026) & (M Units) Table 135. North America Budesonide Sales Market Share by Country (2021-2026) Table 136. North America Budesonide Sales Forecast by Country (2027-2032) & (M Units) Table 137. North America Budesonide Sales Market Share Forecast by Country (2027-2032) Table 138. North America Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Budesonide Market Share by Country (2021-2026) Table 141. North America Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Budesonide Market Share Forecast by Country (2027-2032) Table 143. Europe Budesonide Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 144. Europe Budesonide Sales by Country (2021-2026) & (M Units) Table 145. Europe Budesonide Sales Market Share by Country (2021-2026) Table 146. Europe Budesonide Sales Forecast by Country (2027-2032) & (M Units) Table 147. Europe Budesonide Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Budesonide Market Share by Country (2021-2026) Table 151. Europe Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Budesonide Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Budesonide Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Budesonide Sales by Country (2021-2026) & (M Units) Table 155. Asia-Pacific Budesonide Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Budesonide Sales Forecast by Country (2027-2032) & (M Units) Table 157. Asia-Pacific Budesonide Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Budesonide Market Share by Country (2021-2026) Table 161. Asia-Pacific Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Budesonide Market Share Forecast by Country (2027-2032) Table 163. Latin America Budesonide Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 164. Latin America Budesonide Sales by Country (2021-2026) & (M Units) Table 165. Latin America Budesonide Sales Market Share by Country (2021-2026) Table 166. Latin America Budesonide Sales Forecast by Country (2027-2032) & (M Units) Table 167. Latin America Budesonide Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Budesonide Market Share by Country (2021-2026) Table 171. Latin America Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Budesonide Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Budesonide Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Budesonide Sales by Country (2021-2026) & (M Units) Table 175. Middle East and Africa Budesonide Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Budesonide Sales Forecast by Country (2027-2032) & (M Units) Table 177. Middle East and Africa Budesonide Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Budesonide Market Share by Country (2021-2026) Table 181. Middle East and Africa Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Budesonide Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Budesonide Distributors List Table 186. Budesonide Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Budesonide Image Figure 2. Global Budesonide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Budesonide Market Size (2021-2032) & (US$ Million) Figure 4. Global Budesonide Sales (2021-2032) & (M Units) Figure 5. Injectable Suspension Image Figure 6. Global Injectable Suspension Sales YoY Growth (2021-2032) & (M Units) Figure 7. Aerosols Image Figure 8. Global Aerosols Sales YoY Growth (2021-2032) & (M Units) Figure 9. Inhalation Powder Image Figure 10. Global Inhalation Powder Sales YoY Growth (2021-2032) & (M Units) Figure 11. Tablet and Capsule Image Figure 12. Global Tablet and Capsule Sales YoY Growth (2021-2032) & (M Units) Figure 13. Global Budesonide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Budesonide Market Share by Type 2025 VS 2032 Figure 15. North America Budesonide Sales Market Share in Volume by Type in 2025 Figure 16. North America Budesonide Sales Market Share in Value by Type in 2025 Figure 17. Europe Budesonide Sales Market Share in Volume by Type in 2025 Figure 18. Europe Budesonide Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Budesonide Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Budesonide Sales Market Share in Value by Type in 2025 Figure 21. Latin America Budesonide Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Budesonide Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Budesonide Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Budesonide Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Budesonide Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Respiratory Disease Treatment Image Figure 28. Global Respiratory Disease Treatment Sales YoY Growth (2021-2032) & (M Units) Figure 29. Nose Disease Treatment Image Figure 30. Global Nose Disease Treatment Sales YoY Growth (2021-2032) & (M Units) Figure 31. Inflammatory Bowel Disease Treatment Image Figure 32. Global Inflammatory Bowel Disease Treatment Sales YoY Growth (2021-2032) & (M Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 35. Global Budesonide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Budesonide Market Share by Application 2025 VS 2032 Figure 37. North America Budesonide Sales Market Share in Volume by Application in 2025 Figure 38. North America Budesonide Sales Market Share in Value by Application in 2025 Figure 39. Europe Budesonide Sales Market Share in Volume by Application in 2025 Figure 40. Europe Budesonide Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Budesonide Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Budesonide Sales Market Share in Value by Application in 2025 Figure 43. Latin America Budesonide Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Budesonide Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Budesonide Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Budesonide Sales Market Share in Value by Application in 2025 Figure 47. North America Budesonide Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 48. North America Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Budesonide Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 52. Europe Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Budesonide Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 56. Asia-Pacific Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Budesonide Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 60. Latin America Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Budesonide Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 64. Middle East and Africa Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Budesonide Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Budesonide Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Suspension
  • Aerosols
  • Inhalation Powder
  • Tablet and Capsule
Applications
  • Respiratory Disease Treatment
  • Nose Disease Treatment
  • Inflammatory Bowel Disease Treatment
  • Others
Companies covered
  • AstraZeneca
  • Teva
  • Mylan
  • Sandoz
  • Cosmo Pharmaceuticals
  • Salix
  • Chiesi Farmaceutici
  • Orion Corporation
  • Cipla
  • Synmosa Biopharma
  • Lunan Better Pharma
  • Shanghai Sine Promod

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Budesonide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Budesonide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Budesonide Market by Type
  6. 1.3.1 Injectable Suspension
  7. 1.3.2 Aerosols
  8. 1.3.3 Inhalation Powder
  9. 1.3.4 Tablet and Capsule
  10. 1.4 Global Budesonide Market Size by Type
  11. 1.4.1 Global Budesonide Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Budesonide Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Budesonide Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Budesonide Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Budesonide Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Budesonide Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Budesonide Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Budesonide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Budesonide Industry Trends
  2. 2.2 Budesonide Industry Drivers
  3. 2.3 Budesonide Industry Opportunities and Challenges
  4. 2.4 Budesonide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Budesonide Revenue (2021-2026)
  2. 3.2 Global Top Players by Budesonide Sales (2021-2026)
  3. 3.3 Global Top Players by Budesonide Price (2021-2026)
  4. 3.4 Global Budesonide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Budesonide Major Company Production Sites & Headquarters
  6. 3.6 Global Budesonide Company, Product Type & Application
  7. 3.7 Global Budesonide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Budesonide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Budesonide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Budesonide Tier 1, Tier 2, and Tier 3
4 Budesonide Regional Status and Outlook
  1. 4.1 Global Budesonide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Budesonide Historic Market Size by Region
  3. 4.2.1 Global Budesonide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Budesonide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Budesonide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Budesonide Forecasted Market Size by Region
  7. 4.3.1 Global Budesonide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Budesonide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Budesonide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Budesonide by Application
  1. 5.1 Budesonide Market by Application
  2. 5.1.1 Respiratory Disease Treatment
  3. 5.1.2 Nose Disease Treatment
  4. 5.1.3 Inflammatory Bowel Disease Treatment
  5. 5.1.4 Others
  6. 5.2 Global Budesonide Market Size by Application
  7. 5.2.1 Global Budesonide Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Budesonide Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Budesonide Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Budesonide Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Budesonide Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Budesonide Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Budesonide Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Budesonide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Budesonide Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Budesonide Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Budesonide Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Sandoz
  20. 6.4.1 Sandoz Company Information
  21. 6.4.2 Sandoz Business Overview
  22. 6.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sandoz Budesonide Product Portfolio
  24. 6.4.5 Sandoz Recent Developments
  25. 6.5 Cosmo Pharmaceuticals
  26. 6.5.1 Cosmo Pharmaceuticals Company Information
  27. 6.5.2 Cosmo Pharmaceuticals Business Overview
  28. 6.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cosmo Pharmaceuticals Budesonide Product Portfolio
  30. 6.5.5 Cosmo Pharmaceuticals Recent Developments
  31. 6.6 Salix
  32. 6.6.1 Salix Company Information
  33. 6.6.2 Salix Business Overview
  34. 6.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Salix Budesonide Product Portfolio
  36. 6.6.5 Salix Recent Developments
  37. 6.7 Chiesi Farmaceutici
  38. 6.7.1 Chiesi Farmaceutici Company Information
  39. 6.7.2 Chiesi Farmaceutici Business Overview
  40. 6.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chiesi Farmaceutici Budesonide Product Portfolio
  42. 6.7.5 Chiesi Farmaceutici Recent Developments
  43. 6.8 Orion Corporation
  44. 6.8.1 Orion Corporation Company Information
  45. 6.8.2 Orion Corporation Business Overview
  46. 6.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Orion Corporation Budesonide Product Portfolio
  48. 6.8.5 Orion Corporation Recent Developments
  49. 6.9 Cipla
  50. 6.9.1 Cipla Company Information
  51. 6.9.2 Cipla Business Overview
  52. 6.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cipla Budesonide Product Portfolio
  54. 6.9.5 Cipla Recent Developments
  55. 6.10 Synmosa Biopharma
  56. 6.10.1 Synmosa Biopharma Company Information
  57. 6.10.2 Synmosa Biopharma Business Overview
  58. 6.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Synmosa Biopharma Budesonide Product Portfolio
  60. 6.10.5 Synmosa Biopharma Recent Developments
  61. 6.11 Lunan Better Pharma
  62. 6.11.1 Lunan Better Pharma Company Information
  63. 6.11.2 Lunan Better Pharma Business Overview
  64. 6.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lunan Better Pharma Budesonide Product Portfolio
  66. 6.11.5 Lunan Better Pharma Recent Developments
  67. 6.12 Shanghai Sine Promod
  68. 6.12.1 Shanghai Sine Promod Company Information
  69. 6.12.2 Shanghai Sine Promod Business Overview
  70. 6.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shanghai Sine Promod Budesonide Product Portfolio
  72. 6.12.5 Shanghai Sine Promod Recent Developments
7 North America by Country
  1. 7.1 North America Budesonide Sales by Country
  2. 7.1.1 North America Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Budesonide Sales by Country (2021-2026)
  4. 7.1.3 North America Budesonide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Budesonide Market Size by Country
  6. 7.2.1 North America Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Budesonide Market Size by Country (2021-2026)
  8. 7.2.3 North America Budesonide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Budesonide Sales by Country
  2. 8.1.1 Europe Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Budesonide Sales by Country (2021-2026)
  4. 8.1.3 Europe Budesonide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Budesonide Market Size by Country
  6. 8.2.1 Europe Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Budesonide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Budesonide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Budesonide Sales by Country
  2. 9.1.1 Asia-Pacific Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Budesonide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Budesonide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Budesonide Market Size by Country
  6. 9.2.1 Asia-Pacific Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Budesonide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Budesonide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Budesonide Sales by Country
  2. 10.1.1 South America Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Budesonide Sales by Country (2021-2026)
  4. 10.1.3 South America Budesonide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Budesonide Market Size by Country
  6. 10.2.1 South America Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Budesonide Market Size by Country (2021-2026)
  8. 10.2.3 South America Budesonide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Budesonide Sales by Country
  2. 11.1.1 Middle East and Africa Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Budesonide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Budesonide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Budesonide Market Size by Country
  6. 11.2.1 Middle East and Africa Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Budesonide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Budesonide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Budesonide Value Chain Analysis
  2. 12.1.1 Budesonide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Budesonide Production Mode & Process
  7. 12.2 Budesonide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Budesonide Distributors
  10. 12.2.3 Budesonide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst